Evidence map›Paper›PMID 32067690›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2020

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

N W Clarke, A Ali, F C Ingleby, A Hoyle, C L Amos, G Attard, C D Brawley, J Calvert, S Chowdhury, A Cook and 41 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

51 authors.

N W ClarkeDepartment of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester. Electronic address: noel.clarke@christie.nhs.uk.
A AliGenito-Urinary Cancer Research Group, Division of Cancer Sciences, The University of Manchester, Manchester.
F C InglebyMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London; London School of Hygiene and Tropical Medicine, London.
A HoyleDepartment of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester.
C L AmosMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
G AttardUCL Cancer Institute, London.
C D BrawleyMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
J CalvertMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
S ChowdhuryGuy's and Saint Thomas' NHS Foundation Trust, London.
A CookMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
W CrossSt James University Hospital, Leeds.
D P DearnaleyInstitute of Cancer Research, Sutton-London.
H DouisDepartment of Radiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham.
D GilbertMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
S GillessenDivision of Cancer Sciences, The University of Manchester, Manchester.
R J JonesBeatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.
R E LangleyMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
A MacNairMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
Z MalikThe Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.
M D MasonCardiff University, Cardiff.
D MathesonFaculty of Education Health and Wellbeing, University of Wolverhampton, Wolverhampton.
R MillmanMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
C C ParkerInstitute of Cancer Research, Sutton-London; RoyalMarsden NHS Foundation Trust, London.
A W S RitchieMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
H RushMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
J M RussellInstitute of Cancer Sciences, Beatson West of Scotland Cancer Centre, Glasgow.
J BrownUniversity of Sheffield, Sheffield.
S BeesleyKent Oncology Centre, Maidstone.
A BirtleLancashire Teaching Hospitals NHS Foundation Trust, Preston.
L CapaldiWorcestershire Acute Hospitals NHS Trust, Worcester.
J GalePortsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth.
S GibbsQueen's Hospital, Romford.
A LydonTorbay and South Devon NHS Foundation Trust, Torbay.
A NikapotaSussex Cancer Centre, Brighton.
A OmlinDepartment of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland.
J M O'SullivanCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
O ParikhEast Lancashire Hospitals NHS Trust, Blackburn, UK.
A ProtheroeOxford University Hospitals NHS Foundation Trust, Oxford, UK.
S RudmanGuy's and Saint Thomas' NHS Foundation Trust, London.
N N SrihariShrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.
M SimmsHull and East Yorkshire Hospitals NHS Trust, Hull, UK.
J S TanguayVelindre Cancer Centre, Cardiff, UK.
S TolanThe Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool.
J WagstaffSwansea University College of Medicine, Swansea, UK.
J WallaceBeatson West of Scotland Cancer Centre, University of Glasgow, Glasgow.
J WylieThe Christie NHS Foundation Trust, Manchester, UK.
A ZarkarHeartlands Hospital, Birmingham, UK.
M R SydesMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
M K B ParmarMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London.
N D JamesInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
STAMPEDE investigators

Funding

Cancer Research UK 3804
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32067690
PMCPMC8929236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.